Latest News

Gold drifts lower from seven-week peak, US inflation data looms

Aug 10 (Reuters) – Gold slipped on Monday as investors took profits after prices hit ‌a seven-week high in the previous session, while markets looked to U.S. inflation data for fresh clues on the Federal Reserve’s interest rate path. Spot gold was down 0.5% at $4,322.28 per ounce, as ​of 0200 GMT. Prices hit their highest since June 17 on Friday after ​weaker-than-expected U.S. jobs data. U.S. gold futures fell 0.4% to $4,381.60 on ⁠Monday. Get the latest news from India and how it matters to the world with the Reuters India File newsletter. Sign up here. “Gold is edging

Should the shingles vaccine be free for all adults? We asked 5 experts

August 10, 2026 (Conversation) Shingles (herpes zoster) is often thought of as an older person’s disease. But in the past two decades, we’ve seen a rise in reported cases of this viral disease – which causes a painful, blistering rash and nerve pain – among younger adults aged 25–49. To what extent this represents a real rise in cases, or just increased reporting, is not clear. Some people with shingles may not even see a doctor. Shingles is a reactivation of the virus that causes chickenpox (varicella zoster). After a chickenpox infection, the virus lies dormant in nerve tissue and

Gold rises for fourth day to Rs 1.54 lakh/10g in Delhi; silver remains flat

New Delhi, Aug 7 (PTI) Gold prices rose by Rs 200 to Rs 1.54 lakh per 10 grams in the national capital on Friday, tracking a sharp rally in overseas markets as a weaker US dollar and softer crude oil prices lifted bullion demand. Rising for the fourth consecutive session, the yellow metal of 99.9 per cent purity increased by Rs 200 to Rs 1,54,000 per 10 grams (inclusive of all taxes) from Thursday’s closing level of Rs 1,53,800 per 10 grams, according to local traders. However, silver remained unchanged at Rs 2,34,800 per kilogram (inclusive of all taxes) after

ADHD diagnoses and prescriptions have increased globally across all age groups, our review shows

August 7, 2026 (Conversation) Diagnoses for attention deficit hyperactivity disorder (ADHD) have increased in many countries across all age groups, our latest review has found. We have also shown that prescriptions for ADHD treatments have seen similar increases across all age groups. Our latest review, published in the Journal of Psychopharmacology, drew together the recently published research on ADHD diagnoses and prescriptions across the world. We found that in the UK, increases in recorded ADHD diagnoses and treatment prescriptions occurred across all age groups between 2000 and 2018. The greatest rise in ADHD diagnoses across this period was among children.

1 … 33 34 35 36 37 … 1,686